Navigation Links
EULAR driving research and innovation in rheumatic and RMDs in Europe

The European League Against Rheumatism (EULAR) has announced today at its Annual Congress major successes in driving the public agenda for addressing the escalating burden of RMDs in Europe. These advances include:

Recognition for Rheumatic and Musculoskeletal Diseases (RMDs) from major European Commission research initiative, Horizon 2020 'FOREUM', Foundation for Research in Rheumatology, grants research funding for four osteoarthritis projects in its first year.

"It is with great satisfaction that we have seen a progressive dedication of EU research funds for RMDs in recent times. This follows several years of intensive awareness raising activities by EULAR in Brussels," commented Professor Maurizio Cutolo, President of EULAR as well as Chairman of the International League of Associations for Rheumatology (ILAR). "As a result of these activities (including exchanges with EU policy makers and stakeholders), there is now a much better understanding of the real impact of RMDs. There is also consensus about the need to further implement EU actions against these diseases, including in the research field, where EU funds for RMDs related projects have increased in recent years."

EULAR achieves recognition for Rheumatic and Musculoskeletal Diseases from major European Commission research initiative, Horizon 2020

EULAR announces momentous success after achieving recognition for RMDs as one of the five major chronic diseases to be addressed by Horizon 2020, Europe's largest ever EU Research and Innovation programme.

Following more than a decade of public affairs activity, EULAR's priority over the past 24 months has been to be recognised as a major condition in the new research framework programme, Horizon 2020, which was initiated on 1 January 2014.

Neil Betteridge, Liaison Officer, Public Affairs, EULAR commented, "I am delighted to report that after much hard work on the part of many people, including many EULAR members at a national level, the legislative text of the new research framework programme now lists RMDs as a major disease alongside a select number of others including cancer, cardiac disease, mental illness and diabetes. To this end, 2013-'14 has seen major successes for EULAR in its effort to influence the European Parliament, the Commission and the Council."

He continued, "The challenge now for EULAR is to ensure that as many calls for funding as possible relate to RMDs. We know that the vast majority of calls will not mention specific diseases by name so we must position RMDs as critical in cross-cutting areas such as prevention, innovation and healthy ageing in order to maximise the flow of research funds to our area."

'FOREUM', Foundation for Research in Rheumatology, grants research funding for four osteoarthritis projects in its first year

The European Rheumatology Research Foundation (ERRF), established by EULAR in 2013, has been renamed FOREUM (pronounced [fo:rəm]), Foundation for Research in Rheumatology. Since its launch, FOREUM has awarded grant funding to four research projects in the field of osteoarthritis.

"EULAR has been the driving force in creating this important research foundation. FOREUM will not only support rheumatology research in Europe, it will also constitute a forum for deliberations on the future rheumatology research arena," commented Professor Josef Smolen, FOREUM President.

"We received 46 funding applications following our 2013 call for research proposals and were proud to select four projects following a peer review process. Osteoarthritis affects a substantial proportion of the European population and FOREUM would like to congratulate the successful teams focussing on this important area of research," he continued.


Contact: EULAR Press Office
European League Against Rheumatism

Related medicine news :

1. Crescendo Bioscience to present multiple studies at 2014 EULAR Meeting
2. Register today for EULAR 2014!
3. EULAR 2014 -- Register today!
4. EULAR issues updated rheumatoid arthritis management recommendations
5. Parents just as likely to use cell phones while driving, putting child passengers at risk
6. Teens who use alcohol and marijuana together are at higher risk for unsafe driving
7. NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer
8. New MADD Report Reveals Improvement on Drunk Driving Reform Nationwide
9. Driving Fear Program Review
10. How This Program Helps People Conquer Their Fear Without Any Medication – Vinamy
11. Snowstorm’s Here, Be Safe with New Young Drivers® Winter Driving Website Course
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: